TAM
Trust Asset Management Portfolio holdings
AUM
$1.35B
This Quarter Return
+11.56%
1 Year Return
+17.52%
3 Year Return
+80.2%
5 Year Return
+131.52%
10 Year Return
–
AUM
$1.04B
AUM Growth
+$1.04B
(+12%)
Cap. Flow
+$4.22M
Cap. Flow
% of AUM
0.41%
Top 10 Holdings %
Top 10 Hldgs %
76.4%
Holding
215
New
21
Increased
3
Reduced
13
Closed
1
Top Buys
| 1 |
Blackstone
BX
|
$1.09M |
| 2 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$966K |
| 3 |
Real Estate Select Sector SPDR Fund
XLRE
|
$760K |
| 4 |
Airbnb
ABNB
|
$700K |
| 5 |
Pultegroup
PHM
|
$271K |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$766K |
| 2 |
Apple
AAPL
|
$654K |
| 3 |
Energy Select Sector SPDR Fund
XLE
|
$431K |
| 4 |
Alphabet (Google) Class C
GOOG
|
$385K |
| 5 |
Johnson & Johnson
JNJ
|
$295K |
Sector Composition
| 1 | Technology | 12.88% |
| 2 | Financials | 5.56% |
| 3 | Healthcare | 5.5% |
| 4 | Consumer Discretionary | 4.6% |
| 5 | Communication Services | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Applied Materials
AMAT
$126B
| $1.58M | 0.15% |
9,762
| – | – |
|
52
Nike
NKE
$110B
| $1.57M | 0.15% |
14,468
| – | – |
|
53
Lowe's Companies
LOW
$145B
| $1.56M | 0.15% |
7,016
| – | – |
|
54
Goldman Sachs
GS
$221B
| $1.52M | 0.15% |
3,931
| – | – |
|
55
Booking.com
BKNG
$178B
| $1.49M | 0.14% |
421
-36
| -8% | -$128K |
|
56
Morgan Stanley
MS
$237B
| $1.43M | 0.14% |
15,376
| – | – |
|
57
Citigroup
C
$173B
| $1.4M | 0.14% |
27,234
| – | – |
|
58
AT&T
T
$208B
| $1.38M | 0.13% |
82,154
| – | – |
|
59
Intuitive Surgical
ISRG
$167B
| $1.37M | 0.13% |
4,051
| – | – |
|
60
Blackrock
BLK
$172B
| $1.34M | 0.13% |
1,648
-90
| -5% | -$73.1K |
|
61
American Express
AXP
$229B
| $1.3M | 0.13% |
6,944
| – | – |
|
62
Medtronic
MDT
$120B
| $1.29M | 0.12% |
15,600
| – | – |
|
63
Starbucks
SBUX
$101B
| $1.28M | 0.12% |
13,353
| – | – |
|
64
Charles Schwab
SCHW
$173B
| $1.28M | 0.12% |
18,604
| – | – |
|
65
Elevance Health
ELV
$72.5B
| $1.28M | 0.12% |
2,711
-160
| -6% | -$75.5K |
|
66
TJX Companies
TJX
$155B
| $1.26M | 0.12% |
13,455
| – | – |
|
67
Bristol-Myers Squibb
BMY
$96.5B
| $1.26M | 0.12% |
24,521
| – | – |
|
68
Lam Research
LRCX
$122B
| $1.22M | 0.12% |
1,558
| – | – |
|
69
Vertex Pharmaceuticals
VRTX
$103B
| $1.2M | 0.12% |
2,940
| – | – |
|
70
CVS Health
CVS
$93.9B
| $1.19M | 0.12% |
15,079
| – | – |
|
71
Stryker
SYK
$149B
| $1.17M | 0.11% |
3,896
| – | – |
|
72
Analog Devices
ADI
$121B
| $1.16M | 0.11% |
5,863
| – | – |
|
73
Gilead Sciences
GILD
$140B
| $1.16M | 0.11% |
14,275
| – | – |
|
74
Chubb
CB
$110B
| $1.09M | 0.11% |
4,830
| – | – |
|
|
75
Blackstone
BX
$132B
| $1.09M | 0.11% |
+8,305
| New | +$1.09M |
|